Bookrunners Ladenburg Thalmann and Craig-Hallum Capital Group assist
By Devika Patel
Knoxville, Tenn., June 14 – Viveve Medical, Inc. said it priced a $13.5 million public sale of stock with a $2.03 million greenshoe. The deal was announced May 24.
The company will sell 2.7 million common shares at $5.00 per share. The price per share is identical to the June 13 closing share price.
Ladenburg Thalmann & Co. Inc. and Craig-Hallum Capital Group are the bookrunners.
Settlement is expected on June 17.
Proceeds will be used for general corporate purposes.
Based in Sunnyvale, Calif., Viveve is a medical device company.
| Issuer: | Viveve Medical, Inc.
|
| Issue: | Common stock
|
| Amount: | $13.5 million
|
| Greenshoe: | $2,025,000, or 405,000 shares
|
| Shares: | 2.7 million
|
| Price: | $5.00
|
| Warrants: | No
|
| Bookrunners: | Ladenburg Thalmann & Co. Inc. and Craig-Hallum Capital Group
|
| Co-manager: | Maxim Group LLC
|
| Announcement date: | May 24
|
| Pricing date: | June 14
|
| Settlement date: | June 17
|
| Stock symbol: | Nasdaq: VIVE
|
| Stock price: | $5.00 at close June 13
|
| Market capitalization: | $77.75 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
